AtriCure (ATRC) Total Current Liabilities (2010 - 2026)
AtriCure (ATRC) posted quarterly Total Current Liabilities of $81.9 million for Q2 2026, up 18.99% year-over-year from $68.8 million in Q2 2025, and up 11.92% quarter-over-quarter from $73.2 million in Q1 2026.
AtriCure (ATRC) Total Current Liabilities (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Total Current Liabilities for 17 consecutive years, with $81.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities rose 18.99% year-over-year to $81.9 million; the TTM figure through Jun 2026 stood at $81.9 million (up 18.99% YoY), while the FY2025 annual figure was $81.5 million, up 11.03% from the prior year.
- Total Current Liabilities advanced to $81.9 million in Q2 2026 per ATRC's latest filing, from $73.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $82.5 million in Q3 2023 and bottomed at $47.4 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $68.1 million across 5 years, with a median of $70.1 million in 2023.
- Annual changes were most pronounced in 2022 — Total Current Liabilities retreated 18.97% — and 2023, when it jumped 43.3%.
- AtriCure's Total Current Liabilities stood at $58.4 million in 2022, then climbed by 27.7% to $74.6 million in 2023, then decreased by 1.54% to $73.4 million in 2024, then gained by 11.03% to $81.5 million in 2025, then gained by 0.49% to $81.9 million in 2026.
- Business Quant data shows ATRC's Total Current Liabilities at $81.9 million in Q2 2026, $73.2 million in Q1 2026, and $81.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.59 Bn |
| 10 | AtriCure | 2.39 Bn | 2.22 Bn | 118.63 Mn | 81.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.92 Mn |
| Mar 31, 2026 | 73.19 Mn |
| Dec 31, 2025 | 81.52 Mn |
| Sep 30, 2025 | 77.84 Mn |
| Jun 30, 2025 | 68.84 Mn |
| Mar 31, 2025 | 61.22 Mn |
| Dec 31, 2024 | 73.42 Mn |
| Sep 30, 2024 | 74.43 Mn |
| Jun 30, 2024 | 61.23 Mn |
| Mar 31, 2024 | 61.25 Mn |
| Dec 31, 2023 | 74.57 Mn |
| Sep 30, 2023 | 82.54 Mn |
| Jun 30, 2023 | 71.41 Mn |
| Mar 31, 2023 | 62.47 Mn |
| Dec 31, 2022 | 58.39 Mn |
| Sep 30, 2022 | 57.60 Mn |
| Jun 30, 2022 | 56.32 Mn |
| Mar 31, 2022 | 47.38 Mn |
| Dec 31, 2021 | 56.45 Mn |
| Sep 30, 2021 | 53.95 Mn |